Epilepsy Talk
Treating Seizures — 7 Amazing New Breakthroughs
15 Comments
What if you could predict an oncoming seizure in time for you stop it? Or even prevent it?
That day may be coming sooner than you think, thanks to these seven new technologies.
You’ll learn what they are, how they work and how far along they are.
Hidden hospital bill gouging…gone!
5 Comments
In April 2017, a man named Drew Calver thought he was dying. A heart attack had pinned him to the floor of his bedroom. His neighbor took him to St. David’s Medical Center in Austin, where he was successfully treated.
Weeks later, he received a bill from the hospital: That’ll be $108,951.31, please. St. David’s was out of network on his insurance, and Aetna had only paid $55,840 of the total $164,941 bill for his treatment.
New! A breakthrough in non invasive brain surgery
8 Comments
It’s called PING…
This is exciting stuff. In fact, I just read about it now.
It was written about in Science Daily, just yesterday…and in Neuroscience News, six days ago.
Tags: breakthrough, medication resistent, neurological diseases, neurology, non invasive, PING, revolutionize, ultrasound
$56,000 a year for an unproven drug!
Leave a Comment
Getting the FDA to retract a decision, is like getting the toothpaste back in the tube, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all star Alzheimer’s drug aducanumab.
Whether it’s “yes” or “no,” there is no “maybe so”.
Tags: $56000 a year, aducanumab, Alzheimer’s, efficiency, FDA, not proven, patients, risk, side-effects
What’s Really In Your Meds?
5 Comments
“As Americans become more concerned about quality issues with prescription medications made abroad, one company is trying to offer an additional layer of reassurance — by doing chemical analysis before dispensing drugs to patients.
Tags: anti-convulsant medications, chemical analysis, China, consistency, contaminents, correct dosage, FDA, generics and name brand drugs, global drug supply, India, level of quality control, media attention, pharmaceutical supply chain, prescription medications, quality data, quality issues, quality scores, ranking manufacturers, relapses, safety, side effects, third-party check, variability
BIG Pharma’s Outsized Profits
3 Comments
Just how profitable is the pharmaceutical industry?
A study indicates that the profits gained by drug developers outpaced those of other publicly-traded companies by a wide margin over an 18-year period.
Merck & Co., long a standard bearer for the U.S. pharmaceutical industry, earned $10 billion in profits last year. Pfizer, its larger peer, booked even more: $16 billion.
Tags: BIG Pharma, money, new drugs, price gouging, price of prescription drugs, profitability, profits, unaffordable drugs
Hospitals Criticized For Keeping Quiet On Charity Care…
3 Comments
“Too many nonprofit hospitals fail to adequately publicize their charity-care programs, two advocacy groups say in a survey report…”
Tags: charity care, criticized, free or discounted care, indebted patients, nonprofit hospitals, under-insured, unpaid bills
A ‘Pacemaker’ for the Brain…Reducing Seizures by as Much as 50%…and Depression up to 30%
3 Comments
Some people know Deep Brain Stimulation (DBS) as a treatment for epilepsy, reducing seizures by as much as 50 percent.
It’s designed for the considerable number of patients suffering from medically refractory epilepsy who are not candidates for for resective brain surgery.
This tiny pacemaker-like device, is implanted in the brain to deliver a small amount of electricity when it detects the onset of a seizure.
But, what most people DON’T know know is that Deep Brain Stimulation, can help depression by up to 30 per cent.
Tags: can help depression by up to 30%, DBS, Deep Brain Stimulation, emotions, individualized, nearly 1/3 of the more than 250 million people with depression, one size does not fit all, pacemaker-like device, reducing seizures bu as much as 50%, tiny
What Is the FDA Thinking?
3 Comments
Getting the FDA to retract a decision is like getting the toothpaste back into the tube, once it’s been squeezed out.
Take the current all-star Alzheimer’s drug aducanumab. It’s not a proven but it IS approved. To the hefty price tag of $56,000 a year!
About the author
Epilepsy Talk 